Kyle Piskel

Chief Financial Officer, Adaptive Biotechnologies Corp

Bought, 12 months

$0.0M

Sold, 12 months

$3.6M

Companies

Latest trade

May 18, 2026

Companies

Adaptive Biotechnologies CorpChief Financial Officer −$3.6M

Trades

ADPT Sold 3,115 shares at $13.04 $0.0M May 18

ADPT Sold 18,672 shares at $13.17 $0.2M Mar 11

ADPT Sold 2,145 shares at $18.46 · planned $0.0M Feb 4

ADPT Sold 4,290 shares at $18.00 · planned $0.1M Jan 12

ADPT Sold 162,820 shares at $19.50 · planned $3.2M Nov 28

ADPT Sold 238 shares at $14.05 $0.0M Nov 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.